ALAMEDA, Calif. — InSite Vision has launched a phase 1/2 clinical trial of a topical anti-inflammatory product for reducing the pain and inflammation linked with ocular surgery, the company announced. The randomized, placebo-controlled trial will assess the safety, efficacy and pharmacokinetics of ISV-303, a formulation of a low concentration of bromfenac and the company’s DuraSite [...]